These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 25199777)

  • 21. Comparative in vitro activities of tigecycline and 11 other antimicrobial agents against 215 epidemiologically defined multidrug-resistant Acinetobacter baumannii isolates.
    Seifert H; Stefanik D; Wisplinghoff H
    J Antimicrob Chemother; 2006 Nov; 58(5):1099-100. PubMed ID: 16980293
    [No Abstract]   [Full Text] [Related]  

  • 22. Prevalence and Characterization of Integrons in Multidrug Resistant Acinetobacter baumannii in Eastern China: A Multiple-Hospital Study.
    Chen J; Li H; Yang J; Zhan R; Chen A; Yan Y
    Int J Environ Res Public Health; 2015 Aug; 12(8):10093-105. PubMed ID: 26308028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study on the resistant genes to carbapenems and epidemiological characterization of multidrug-resistant Acinetobacter baumannii isolates.
    Jiang W; Liu H; Zhong M; Yang YC; Xiao DW; Huang WF
    Microb Drug Resist; 2013 Apr; 19(2):117-23. PubMed ID: 22845773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trend of extensively drug-resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3-year period.
    Jasemi S; Douraghi M; Adibhesami H; Zeraati H; Rahbar M; Boroumand MA; Aliramezani A; Ghourchian S; Mohammadzadeh M
    Lett Appl Microbiol; 2016 Dec; 63(6):466-472. PubMed ID: 27626896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multidrug resistant Acinetobacter baumannii: a descriptive study in a city hospital.
    Dent LL; Marshall DR; Pratap S; Hulette RB
    BMC Infect Dis; 2010 Jul; 10():196. PubMed ID: 20609238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
    Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii.
    García-Quintanilla M; Carretero-Ledesma M; Moreno-Martínez P; Martín-Peña R; Pachón J; McConnell MJ
    Int J Antimicrob Agents; 2015 Dec; 46(6):696-702. PubMed ID: 26391380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends in antimicrobial resistance of Acinetobacter baumannii clinical isolates from hospitalised patients in Greece and treatment implications.
    Falagas ME; Mourtzoukou EG; Polemis M; Vatopoulos AC;
    Clin Microbiol Infect; 2007 Aug; 13(8):816-9. PubMed ID: 17610601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial potential of lycosin-I, a cationic and amphiphilic peptide from the venom of the spider Lycosa singorensis.
    Tan H; Ding X; Meng S; Liu C; Wang H; Xia L; Liu Z; Liang S
    Curr Mol Med; 2013 Jul; 13(6):900-10. PubMed ID: 23638903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial effects of varied combinations of meropenem, sulbactam, and colistin on a multidrug-resistant Acinetobacter baumannii isolate that caused meningitis and bacteremia.
    Lee CH; Tang YF; Su LH; Chien CC; Liu JW
    Microb Drug Resist; 2008 Sep; 14(3):233-7. PubMed ID: 18707240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Global challenge of multidrug-resistant Acinetobacter baumannii.
    Perez F; Hujer AM; Hujer KM; Decker BK; Rather PN; Bonomo RA
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3471-84. PubMed ID: 17646423
    [No Abstract]   [Full Text] [Related]  

  • 33. Acquisition and clearance of multidrug resistant Acinetobacter baumannii on healthy young adults concurrently burned in a dust explosion in Taiwan: the implication for antimicrobial stewardship.
    Huang PY; Shie SS; Ye JJ; Lin SP; Liu TP; Wu TS; Wu TL; Chuang SS; Cheng MH; Hsieh YC; Huang CT
    BMC Infect Dis; 2017 Aug; 17(1):598. PubMed ID: 28854887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and antimicrobial susceptibility of Acinetobacter spp. isolated from meat.
    Carvalheira A; Casquete R; Silva J; Teixeira P
    Int J Food Microbiol; 2017 Feb; 243():58-63. PubMed ID: 27992816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activities of ceftazidime/avibactam alone or in combination with antibiotics against multidrug-resistant Acinetobacter baumannii isolates.
    Mataracı Kara E; Yılmaz M; Özbek Çelik B
    J Glob Antimicrob Resist; 2019 Jun; 17():137-141. PubMed ID: 30576787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multidrug-resistant Acinetobacter baumannii clone, France.
    Bonnin RA; Cuzon G; Poirel L; Nordmann P
    Emerg Infect Dis; 2013 May; 19(5):822-3. PubMed ID: 23697750
    [No Abstract]   [Full Text] [Related]  

  • 37. Antimicrobial peptides as a promising treatment option against Acinetobacter baumannii infections.
    Neshani A; Sedighian H; Mirhosseini SA; Ghazvini K; Zare H; Jahangiri A
    Microb Pathog; 2020 Sep; 146():104238. PubMed ID: 32387392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
    Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
    Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii.
    Dijkshoorn L; Nemec A; Seifert H
    Nat Rev Microbiol; 2007 Dec; 5(12):939-51. PubMed ID: 18007677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ISAba1 Regulated OXA-23 Carbapenem Resistance in Acinetobacter baumannii Strains in Durban, South Africa.
    Agoba EE; Govinden U; Peer AKC; Osei Sekyere J; Essack SY
    Microb Drug Resist; 2018 Nov; 24(9):1289-1295. PubMed ID: 29653481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.